Tritonix.ai

News / Taiwan / economic_daily

Ruentex-backed Dingjin Biotech Targets 2028 Launch for New Botox Product

Health Technology · Biotechnology · economic_daily · 2026-09-08

7876

Dingjin Biotech, backed by Ruentex Group, has completed Phase III clinical monitoring for its new botulinum toxin, aiming for a 2028 market entry in Taiwan.

What Happened

Clinical Milestones: Dingjin Biotech announced that its novel botulinum toxin, OBI-858, has completed Phase III clinical monitoring in Taiwan, with data unblinding expected in November and a drug license application slated for Q1 next year.

Market Strategy: The company aims to launch the product in Taiwan by the first half of 2028 to capture a share of the multibillion-dollar medical aesthetics market, with an IPO targeted for late 2027.

Safety Profile: Phase II trial results confirmed that OBI-858 maintains high safety and tolerability over one year of repeated use, with most patients requiring minimal treatments to sustain efficacy.

Corporate Backing: Ruentex Group holds approximately 60% of Dingjin Biotech, including a 49% stake held by OBI Pharma, and the company is currently raising over NT$400 million to fund ongoing development.

Read original

More in Health Technology

Joyo Pharm Reports 50% Revenue Surge in August

Health Technology · economic_daily · 2026-09-08

Joyo Pharmaceutical announced a 50% year-over-year revenue increase for August, driven by strong sales in oncology, cardiovascular, and women's health products.

4114

Sandoz CEO Warns Trump's Generic Drug Tariffs Will Burden U.S. Patients

Health Technology · cnbc · 2026-09-08

Sandoz CEO Richard Saynor warns that proposed U.S. tariffs on generic medicines could force manufacturers to hike prices or halt supply, impacting millions of patients.

SDZ-CH, NVO, NVO, NVS

Xufu August Revenue Soars 187.52% Year-over-Year

Health Technology · cnyes · 2026-09-08

Xufu (4119) reported August 2026 revenue of NT$149 million, a 187.52% year-over-year surge, with year-to-date revenue growth at 14.21%.

4119

Latest in Taiwan

Analysts Maintain Bullish Outlook for Taiwan Stocks Amid Three Key Pillars of Support

Electronic Technology · economic_daily · 2026-09-08

Despite recent volatility and profit-taking, analysts remain optimistic about the Taiwan stock market, citing strong fundamentals, technicals, and capital inflows.

3406

Taiwan Stocks Face High-Level Volatility: Three Key Indicators to Watch

Electronic Technology · economic_daily · 2026-09-08

As the Taiwan stock market navigates previous resistance levels, analysts highlight trading volume, TSMC's performance, and foreign futures spreads as critical gauges for future momentum.

2330

AI Demand Drives Record-Breaking August Revenue for Unimicron and Gold Circuit Electronics

Electronic Technology · economic_daily · 2026-09-08

PCB giants Unimicron and Gold Circuit Electronics reported record-high August revenues, fueled by robust AI server demand and seasonal strength.

3037

MA-tek Reports Sixth Consecutive Month of Record Revenue Growth

Electronic Technology · economic_daily · 2026-09-08

Semiconductor testing firm MA-tek achieved record-breaking revenue for the sixth straight month in August, driven by robust demand for AI chip analysis from North American clients.

3587